221
TITLE: Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCAT  Full Text
AUTHORS: João Pedro Ferreira ; Xavier Rossello; Stuart J Pocock; Patrick Rossignol; Brian L Claggett; Jean‐Lucien Rouleau; Scott D Solomon; Bertram Pitt; Marc A Pfeffer; Faiez Zannad;
PUBLISHED: 2020, SOURCE: European Journal of Heart Failure, VOLUME: 22, ISSUE: 9
INDEXED IN: CrossRef: 24
IN MY: ORCID
222
TITLE: The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial
AUTHORS: John G F Cleland; João Pedro Ferreira ; Beatrice Mariottoni; Pierpaolo Pellicori; Joe Cuthbert; Job A J Verdonschot; Johannes Petutschnigg; Fozia Z Ahmed; Franco Cosmi; Hans-Peter Brunner La Rocca; Mamas A Mamas; Andrew L Clark; Frank Edelmann; Burkert Pieske; Javed Khan; Ken McDonald; Philippe Rouet; Jan A Staessen; Blerim Mujaj; Arantxa González; Javier Diez; Mark Hazebroek; Stephane Heymans; Roberto Latini; Stéphanie Grojean; Anne Pizard; Nicolas Girerd; Patrick Rossignol; Tim J Collier; Faiez Zannad; Dan Atar; Lars Kober; Kenneth Dickstein; Theis Lange; ...More
PUBLISHED: 2020, SOURCE: European Heart Journal, VOLUME: 42, ISSUE: 6
INDEXED IN: CrossRef: 76
IN MY: ORCID
224
TITLE: The prevalence and importance of frailty in heart failure with reduced ejection fraction – an analysis of PARADIGM‐HF and ATMOSPHERE  Full Text
AUTHORS: Pooja Dewan; Alice Jackson; Pardeep S Jhund; Li Shen; João Pedro Ferreira ; Mark C Petrie; William T Abraham; Akshay S Desai; Kenneth Dickstein; Lars Køber; Milton Packer; Jean L Rouleau; Scott D Solomon; Karl Swedberg; Michael R Zile; John J.V McMurray;
PUBLISHED: 2020, SOURCE: European Journal of Heart Failure, VOLUME: 22, ISSUE: 11
INDEXED IN: CrossRef: 80
IN MY: ORCID
225
TITLE: Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus  Full Text
AUTHORS: Malik Elharram; Abhinav Sharma; William White; George Bakris; Patrick Rossignol; Cyrus Mehta; João Pedro Ferreira ; Faiez Zannad;
PUBLISHED: 2020, SOURCE: American Heart Journal, VOLUME: 229
INDEXED IN: CrossRef: 4
IN MY: ORCID
226
TITLE: Use of the Win Ratio in Cardiovascular Trials  Full Text
AUTHORS: João Pedro Ferreira ; Pardeep S Jhund; Kévin Duarte; Brian L Claggett; Scott D Solomon; Stuart Pocock; Mark C Petrie; Faiez Zannad; John J.V McMurray;
PUBLISHED: 2020, SOURCE: JACC: Heart Failure, VOLUME: 8, ISSUE: 6
INDEXED IN: CrossRef: 34
IN MY: ORCID
227
TITLE: Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms trial
AUTHORS: Luca Monzo; João Pedro Ferreira ; Paula Abreu; Annette Szumski; Michael Böhm; John J.V McMurray; Bertram Pitt; Karl Swedberg; Dirk J van Veldhuisen; Nicolas Girerd; John Vincent; Faiez Zannad; Patrick Rossignol;
PUBLISHED: 2020, SOURCE: Journal of Hypertension, VOLUME: 38, ISSUE: 3
INDEXED IN: CrossRef: 12
IN MY: ORCID
228
TITLE: A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial
AUTHORS: Mandeep R Mehra; Muthiah Vaduganathan; Min Fu; João Pedro Ferreira ; Stefan D Anker; John G F Cleland; Carolyn S P Lam; Dirk J van Veldhuisen; William M Byra; Theodore E Spiro; Hsiaowei Deng; Faiez Zannad; Barry Greenberg;
PUBLISHED: 2019, SOURCE: European Heart Journal, VOLUME: 40, ISSUE: 44
INDEXED IN: CrossRef: 66
IN MY: ORCID
229
TITLE: Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study
AUTHORS: Ferreira, JP ; Couchoud, C; Gregson, J; Tiple, A; Glowacki, F; London, G; Agarwal, R; Rossignol, P;
PUBLISHED: 2019, SOURCE: NEPHROLOGY DIALYSIS TRANSPLANTATION, VOLUME: 34, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef: 4
IN MY: ORCID
230
TITLE: Balancing Benefits and Risks of Spironolactone in HFpEF and Chronic Kidney Disease Patients  Full Text
AUTHORS: Patrick Rossignol; João Pedro Ferreira ;
PUBLISHED: 2019, SOURCE: JACC: Heart Failure, VOLUME: 7, ISSUE: 1
INDEXED IN: CrossRef: 3
IN MY: ORCID
Página 23 de 32. Total de resultados: 316.